Healthcare reform is real. It is changing the way care is delivered and also the way organizations get reimbursed – shifting to a focus on value and quality of care rather than volume of services. Whether your organization is looking to become an ACO or plans to take on bundled payment initiatives proposed by CMS, rehabilitation providers are adopting value-based rehabilitation models of care spanning the recovery continuum (Acute, SNF, Outpatient, Aftercare).
A multi-site randomized controlled clinical trial performed in the VA healthcare system showed that the cost of delivering robot therapy with InMotion robots was recuperated by lower health care use costs. In fact, each patient in the robot treated group consumed $6,419 less “other” healthcare services during the 36 weeks when healthcare expenses were tracked.
- Reduced inpatient readmissions
- Reduced outpatient office visits
This is the first clinical trial that demonstrates a rehabilitation intervention (robot-assisted therapy) can reduce health care resource utilization and improve patient quality of life.
- Rehabilitation providers are using InMotion Robots to strategically grow and strengthen their
- Across the continuum of recovery InMotion Robots are being adopted and integrated into clinical practice benefiting patients and providers.
- Providers are investing in InMotion robots to align strategic goals with operational performance.
- Bionik’s clinical development specialists can help you create a proven, evidence-based return on investment plan to get your project approved.
Over the last 18 years InMotion Robots have been clinically tested in the clinical inpatient, outpatient and chronic care settings. InMotion Robots are used as a “clinical tool” allowing clinicians to deliver motor training protocols that are interactive, intensive and precisely reproducible, and most importantly have been thoroughly tested with proven clinical efficacy.
As an example, according to the latest stroke rehabilitation guidelines published in the AHA scientific statement, robot assisted therapy should be used for UPPER EXTREMITY motor rehabilitation of severe to moderate stroke patients, in the inpatient, outpatient and chronic care settings.These following statements published in the stroke rehabilitation guidelines referenced randomized controlled clinical trials that utilized InMotion Robots.
Key clinical outcomes
- 30% improvement in FIM® scores compared to the control group
- Results were maintained and patients continued to improve on a 3 year follow up evaluation
- Specifically the AHA made the following two statements:
- “Robot-Assisted UPPER EXTREMITY therapy, however, can improve motor function during the inpatient period after stroke.”
- “Robot-assisted therapy has been shown to improve UPPER EXTREMITY motor function in outpatient and chronic care settings.”
These training protocols are now conveniently available on the clinical version of all InMotion Robots, providing your program with a clear path to evidence-based clinical utilization of robot-assited therapy.
 American Heart Association Scientific Statement Published in Stroke Miller et al. (2010); 41:2402-2448
 Robot training enhanced motor outcome in patients with stroke maintained over 3 years. Neurology. Volpe BT, Krebs HI, Hogan N, Edelsteinn L, Diels CM, Aisen ML. 1999;53:1874 –1876.
Does shorter rehabilitation limit potential recovery poststroke? Neurorehabilitation Neural Repair. Fasoli SE, Krebs HI, Ferraro M, Hogan N, Volpe BT. 2004;18:88 –94.
The effect of robot-assisted therapy and rehabilitative training on motor recovery following stroke. Arch Neurology Aisen ML, Krebs HI, Hogan N, McDowell F, Volpe BT.1997;54:443.
 Intensive sensorimotor arm training mediated by therapist or robot improves hemiparesis in patients with chronic stroke. Neurorehabil Neural Repair Volpe BT, Lynch D, Rykman-Berland A, Ferraro M, Galgano M, Hogan N, Krebs HI. Neurorehabil Neural Repair. 2008;22:305–310.